- Home
- SQFT vs NDRA Comparison
SQFT vs NDRA Comparison
Compare SQFT & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- NDRA
- Stock Information
- Founded
- SQFT 1999
- NDRA 2007
- Country
- SQFT United States
- NDRA United States
- Employees
- SQFT N/A
- NDRA N/A
- Industry
- SQFT Real Estate Investment Trusts
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SQFT Real Estate
- NDRA Health Care
- Exchange
- SQFT Nasdaq
- NDRA Nasdaq
- Market Cap
- SQFT 7.7M
- NDRA 7.3M
- IPO Year
- SQFT 2020
- NDRA 2017
- Fundamental
- Price
- SQFT $5.63
- NDRA $5.73
- Analyst Decision
- SQFT
- NDRA Strong Buy
- Analyst Count
- SQFT 0
- NDRA 1
- Target Price
- SQFT N/A
- NDRA $38.00
- AVG Volume (30 Days)
- SQFT 30.2K
- NDRA 793.8K
- Earning Date
- SQFT 11-11-2025
- NDRA 11-14-2025
- Dividend Yield
- SQFT N/A
- NDRA N/A
- EPS Growth
- SQFT N/A
- NDRA N/A
- EPS
- SQFT N/A
- NDRA N/A
- Revenue
- SQFT $18,052,597.00
- NDRA N/A
- Revenue This Year
- SQFT $23.63
- NDRA N/A
- Revenue Next Year
- SQFT N/A
- NDRA N/A
- P/E Ratio
- SQFT N/A
- NDRA N/A
- Revenue Growth
- SQFT N/A
- NDRA N/A
- 52 Week Low
- SQFT $4.19
- NDRA $2.90
- 52 Week High
- SQFT $23.00
- NDRA $11.96
- Technical
- Relative Strength Index (RSI)
- SQFT 44.38
- NDRA 52.47
- Support Level
- SQFT $5.52
- NDRA $4.85
- Resistance Level
- SQFT $6.40
- NDRA $5.37
- Average True Range (ATR)
- SQFT 0.39
- NDRA 0.41
- MACD
- SQFT -0.02
- NDRA -0.07
- Stochastic Oscillator
- SQFT 23.00
- NDRA 61.23
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.